BOLD (STOCKS)
Boundless Bio, Inc. Common Stock
$2.775000
-0.005000 (-0.18%)
Prev close: $2.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Zachary D. Hornby, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $68.28M
- Employees
- 64
- P/E (TTM)
- -0.97
- P/B (TTM)
- 0.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.00M |
| Operating Expenses | $68.01M |
| Depreciation and Amortization | $2.30M |
| Research and Development | $44.20M |
| Other Operating Expenses | $21.51M |
| Operating Income/Loss | -$68.01M |
| Income/Loss From Continuing Operations After Tax | -$64.01M |
| Income/Loss From Continuing Operations Before Tax | -$64.01M |
| Net Income/Loss | -$64.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$64.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$64.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.85 |
| Diluted Earnings Per Share | -$2.85 |
| Basic Average Shares | 67,256,000 |
| Diluted Average Shares | 67,256,000 |
| Assets | $73.74M |
| Current Assets | $73.65M |
| Cash | $72.60M |
| Other Current Assets | $1.05M |
| Noncurrent Assets | $97.00K |
| Fixed Assets | $97.00K |
| Liabilities | $7.77M |
| Current Liabilities | $7.77M |
| Accounts Payable | $1.05M |
| Wages | $2.77M |
| Other Current Liabilities | $3.94M |
| Noncurrent Liabilities | $0.00 |
| Equity | $65.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $65.98M |
| Liabilities And Equity | $73.74M |
| Net Cash Flow From Operating Activities | -$56.25M |
| Net Cash Flow From Operating Activities, Continuing | -$56.25M |
| Net Cash Flow From Investing Activities | $61.11M |
| Net Cash Flow From Investing Activities, Continuing | $61.11M |
| Net Cash Flow From Financing Activities | $97.00K |
| Net Cash Flow From Financing Activities, Continuing | $97.00K |
| Net Cash Flow | $4.96M |
| Net Cash Flow, Continuing | $4.96M |
| Comprehensive Income/Loss | -$64.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$64.04M |
| Other Comprehensive Income/Loss | $8.04M |